Andrew Scholey is director of the Centre for Human Psychopharmacology and Professor of brain and behavioral sciences at Swinburne University, Melbourne, Vic, Australia and is Co-director of the NICM Collaborative Centre for the Study of Natural Medicines and Neurocognition. His Ph.D. and postdoctoral researched the neurochemical basis of memory formation at the Brain and Behaviour Research Group at the Open University, UK. In 1998, he established the Human Cognitive Neuroscience Unit at Northumbria University, UK and was the Unit’s Director until joining the BSI in 2007. Professor Scholey was also Codirector of the UK’s Medicinal Plant Research Centre and remains as an Honorary Director of neurocognitive trials. Andrew has been a lead investigator in a series of studies into the human biobehavioral effects of natural products, and their neurocognition-enhancing and antistress/anxiolytic properties. These include first-into-human, placebo-controlled trials evaluating Panax ginseng, Panax quinquefolius, Melissa officinalis, Salvia officinalis, Salvia lavandulaefolia, and guaraná. He has also researched the mood and cognitive effects of oxygen, glucose, chewing gum, and water ingestion. He has published over 100 journal articles and has attracted millions of dollars in research funding, including being the Chief Investigator on national competitive grants from the UK, Europe and Australia as well as from many industry bodies in Europe, North America, Asia and Australia. Professor Scholey has supervised around 20 Ph.D.s and over 100 honors students. He is committed to the public dissemination of science with numerous appearances in the print, audiovisual, and digital media.
Biography Updated on 1 April 2012